secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001601485-24-000063
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Elicio Therapeutics annual meeting adjourned due to lack of quorum; reconvened Nov 21
--------------------------------------------------------------------------------

- Virtual annual meeting on Nov 7, 2024 lacked a quorum of common stock holders.
- Meeting adjourned to Nov 21, 2024 at 9:30 a.m. ET; no in-person attendance.
- Existing proxies remain valid; new proxy voting deadline is Nov 20, 2024 11:59 p.m. ET.
- Record date remains Sept 11, 2024; preregistered stockholders need not re-register.
- Majority of received proxies voted in favor of all proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000160148524000063/0001601485-24-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000160148524000063/angn-20241107.htm
  HTML page:      https://secwatch.observer/filing/0001601485-24-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer